Navigation Links
Pradaxa Maker Working on Antidote Amid Pradaxa Bleeding Warnings
Date:7/3/2012

Dallas, TX (PRWEB) July 03, 2012

The Pradaxa Resource Center, a patient advocacy group, is alerting patients who have taken or may be prescribed the drug Pradaxa that the maker of the drug is working on an antidote to help prevent potential deadly internal bleeding problems associated with Pradaxa.

The move comes as the FDA, European Medicines Agency and Institute for Safe Medication Practices have all warned that Pradaxa may cause serious or fatal internal bleeding of the intestines or brain, and a Federal Court is set to consolidate lawsuits filed by victims so far.

Anyone who has suffered a bleeding episode or lost a loved one after Pradaxa use is urged to speak with a lawyer about their legal rights as soon as possible.

Pradaxa is a popular anticoagulant prescribed to patients suffering from atrial fibrillation in order to prevent strokes. According to The Wall Street Journal on April 24, 2012, the drug reached blockbuster status after sales of $1 billion for the 12-month period ending in February.

Unfortunately, the FDA warned on December 7, 2011 that it was investigating the safety of Pradaxa after receiving higher than expected reports of injury or death. On May 25th, the European Medicines Agency also issued a warning on internal bleeding risks.

On June 6th, the Philadelphia Inquirer reported that Pradaxa led all other medications in 2011 for number of deaths and internal bleeding episodes reported to the FDA. The paper cited a report from the Institute for Safe Medication Practices' QuarterWatch program, which tracks reports to the FDA’s MedWatch.

Although all anticoagulants carry a risk of internal bleeding, most have a reversal agent available to doctors in emergency. A March 6, 2012 report by the Journal of Neurosurgery highlighted concerns from doctors that once Pradaxa causes internal bleeding in a patient, there is little they can do to stop it.

Now, Reuters has reported on June 14th that the maker of Pradaxa, German drug manufacturer Boehringer Ingelheim, is working at developing an antidote to the internal bleeding problems.

Due to the number of lawsuits expected over Pradaxa side effects, a motion was recently filed to consolidate the cases into one central federal court. The Motion was filed on May 30, 2012 in Case MDL No. 2385 IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois. In the Motion, lawyers state they expect as many as 500 cases will be filed.

Anyone affected by Pradaxa side effects is urged to speak with a lawyer about their legal options. However, due to the specialized nature of federal MDL cases, only certain lawyers can help. The Pradaxa Resource center works only with qualified lawyers who are already filing these cases. Find out if you may be eligible to file a Pradaxa lawsuit by contacting the resource center.

For more information on the research, warnings, side effects and legal options relating to the drug Pradaxa, or to speak with a lawyer, visit http://www.Pradaxa-lawsuits.org.

Read the full story at http://www.prweb.com/releases/pradaxa-lawsuit/side-effects/prweb9663603.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Approval of Safer Alternative to Pradaxa Delayed by FDA
2. Corporate Whistle Blower Center Now Urges Medical Device Insiders To Be A Whistleblower If They Can Prove The Device Maker Knew Of A Failure & Said Nothing=Huge Rewards
3. Law Firm Aggressively Litigating against Birth Control Makers for their Newer, but Allegedly Unsafer Products: Nuvaring, Yaz, BeYaz, Yasmin, Ocella, Gianvi
4. Pacemakers, Defibrillators Sources of Deadly Infections: Study
5. DotComSecrets Invites Professionals to Learn Great Tips On How to Make a Handsome Income By Working As Local Internet Marketing Consultants
6. Doctors cite concern for patients, colleagues top motives for working sick
7. Moffitt Cancer Center researchers working at frontiers of melanoma research
8. Specialized care by experienced teams cuts death and disability from bleeding brain aneurysms
9. Tragic San Diego Dog Attack Leaves One Infant Dead – California Dog Bite Attorneys Revive Pit Bull Warnings
10. Aim Skin Cancer Warnings at the Young, Too, Experts Say
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica Scruggs ... for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs surgery, ... Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, MD, ...
(Date:6/25/2016)... ... , ... "With 30 hand-drawn hand gesture animations, FCPX users can easily customize ... Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures into ... Simply select a ProHand generator and drag it above media or text in the ...
(Date:6/25/2016)... Beach, CA (PRWEB) , ... June 25, 2016 , ... ... UCLA with Magna Cum Laude and his M.D from the David Geffen School of ... Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at the ...
(Date:6/25/2016)... ... 2016 , ... On Friday, June 10, Van Mitchell, Secretary of the Maryland ... iHire in recognition of their exemplary accomplishments in worksite health promotion. , The Wellness ... & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one of ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June 14 ... The article goes on to state that individuals are now more comfortable seeking to ... operations such as calf and cheek reduction. The Los Angeles area medical group, Beverly ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... of Australia,s successful biotechnology scientists, Dr ... company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). Noxopharm is ... the ASX. Noxopharm is a clinic-ready company with its ... clinical study later this year. ... facing cancer patients - the ability of cancers to become resistant ...
(Date:6/26/2016)... , June 27, 2016 Jazz Pharmaceuticals plc ... period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, ... of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ... (Eastern Daylight Time). As previously announced on ... a definitive merger agreement under which Jazz Pharmaceuticals has ...
(Date:6/26/2016)... Ontario , June 27, 2016  VMS Rehab ... Company,s Board will take whatever measures required to build ... Company,s stock which is currently listed on the OTC ... Wexler, Company Chairman and CEO, "We are seeing an ... difficult to understand, not only by the Company, but ...
Breaking Medicine Technology: